Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inova-CCP: Convalescent Plasma for Severe COVID-19
NCT04502472Phase 3Terminated
- Sponsor
- Inova Health System
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19), sponsored by Inova Health System. Started Jun 2020; status: terminated.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04502472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04502472.